|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-7-2
|
|
pubmed:abstractText |
Prognostic and treatment-predictive biomarkers in primary breast cancer are routinely analyzed in the primary tumor, whereas metastatic tumor cells in lymph node metastases are not characterized. The present study aimed to define the concordance between biomarkers in matched pairs of breast cancers and lymph node metastases and to relate their expression to clinical outcome.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/HER2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1432-2323
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1434-41
|
|
pubmed:meshHeading |
pubmed-meshheading:20213203-Adult,
pubmed-meshheading:20213203-Aged,
pubmed-meshheading:20213203-Aged, 80 and over,
pubmed-meshheading:20213203-Antineoplastic Agents, Hormonal,
pubmed-meshheading:20213203-Breast Neoplasms,
pubmed-meshheading:20213203-Disease-Free Survival,
pubmed-meshheading:20213203-Female,
pubmed-meshheading:20213203-Humans,
pubmed-meshheading:20213203-Immunohistochemistry,
pubmed-meshheading:20213203-Ki-67 Antigen,
pubmed-meshheading:20213203-Lymph Nodes,
pubmed-meshheading:20213203-Lymphatic Metastasis,
pubmed-meshheading:20213203-Middle Aged,
pubmed-meshheading:20213203-Prognosis,
pubmed-meshheading:20213203-Receptor, erbB-2,
pubmed-meshheading:20213203-Receptors, Estrogen,
pubmed-meshheading:20213203-Receptors, Progesterone,
pubmed-meshheading:20213203-Tamoxifen,
pubmed-meshheading:20213203-Tissue Array Analysis,
pubmed-meshheading:20213203-Tumor Markers, Biological
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
|
|
pubmed:affiliation |
Department of Surgery, Institution of Clinical Sciences Lund, Lund University Hospital, SE-221 85, Lund, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
